These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 32925909)

  • 21. Long-Acting Reversible Contraception Free of Charge, Method Initiation, and Abortion Rates in Finland.
    Gyllenberg F; Juselius M; Gissler M; Heikinheimo O
    Am J Public Health; 2018 Apr; 108(4):538-543. PubMed ID: 29470111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Acting Reversible Contraceptive Uptake before and after the Affordable Care Act Contraceptive Mandate in Women Undergoing First Trimester Surgical Abortion.
    Bell KN; Meyn LA; Chen BA
    Womens Health Issues; 2018; 28(4):301-305. PubMed ID: 29853173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Provision of long-acting reversible contraception at surgical abortion-A cross-sectional nationwide register study.
    Hogmark S; Envall N; Wikman A; Skoglund C; Kopp Kallner H; Hesselman S
    Acta Obstet Gynecol Scand; 2022 Jan; 101(1):77-83. PubMed ID: 34761384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contraceptive uptake and compliance after structured contraceptive counseling - secondary outcomes of the LOWE trial.
    Bizjak I; Envall N; Emtell Iwarsson K; Kopp Kallner H; Gemzell-Danielsson K
    Acta Obstet Gynecol Scand; 2024 May; 103(5):873-883. PubMed ID: 38351571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining long-acting reversible contraception non-use among Australian women in their 20s: findings from a qualitative study.
    Coombe J; Harris ML; Loxton D
    Cult Health Sex; 2019 Jul; 21(7):822-836. PubMed ID: 30612512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake of long-acting reversible contraception after telemedicine delivered abortion during Covid-19.
    Dixon A; Reynolds-Wright JJ; Cameron ST
    Eur J Contracept Reprod Health Care; 2022 Aug; 27(4):284-288. PubMed ID: 35713651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraception after Abortion and Risk of Repeated Unintended Pregnancy among Health Plan Members.
    Postlethwaite D; Lee J; Merchant M; Alabaster A; Raine-Bennett T
    Perm J; 2018; 22():18-058. PubMed ID: 30227910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal trends in uptake of hormonal long-acting reversible contraception devices throughout the COVID-19 pandemic: an Australian population-based study.
    Stevenson TB; Rumbold AR; Moore V; Hall K; Ilomaki J; Mazza D; Bateson D; Grzeskowiak LE
    BMJ Sex Reprod Health; 2024 Oct; 50(4):262-269. PubMed ID: 38719618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Permanent and long-acting reversible contraception volumes at a multihospital system in Ohio before and after Dobbs.
    Mitchell JA; Yao M; Maeda R; Lappen JR; Brant AR
    Contraception; 2024 Sep; 137():110471. PubMed ID: 38648922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: A systematic review.
    Buckingham P; Moulton JE; Subasinghe AK; Amos N; Mazza D
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):629-640. PubMed ID: 33608901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with the uptake of long-acting reversible contraception among female sex workers in post-conflict Northern Uganda: a cross-sectional study.
    Ouma S; Tumwesigye NM; Abbo C; Ndejjo R
    Reprod Health; 2022 Feb; 19(1):34. PubMed ID: 35109873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contraceptive choice at the time of a surgical and pharmacological abortion: a possible and effective option thanks to a dedicate counselling.
    Algeri P; Colonna L; Savoldi V; Imbruglia L; Mastrocola N; Von Wunster S
    Eur J Contracept Reprod Health Care; 2023 Oct; 28(5):263-267. PubMed ID: 37590091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods.
    Pace LE; Dusetzina SB; Keating NL
    Med Care; 2016 Sep; 54(9):811-7. PubMed ID: 27213549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and correlates of postabortion long-acting reversible contraceptive (LARC) use among young women (24 and below) in Nepal: Strategy in the search for improvements.
    Mehata S; Bhattarai N; Menzel J; Shah M; Khanal P; Tofigh S; Khanal MN; Regmi SC; Andersen K
    Reprod Health; 2019 May; 16(1):55. PubMed ID: 31088518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective observational study of interventions to improve acceptance of long-acting reversible contraception following abortion at Lusaka Teaching Hospital, Zambia.
    Macha S; Muyuni M; Nkonde S; Pádua KS; Faundes A
    Int J Gynaecol Obstet; 2018 Apr; 141(1):32-36. PubMed ID: 29243249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.